Clinical Application of Pharmacogenetic Markers in the Treatment of Dermatologic Pathologies

Clinical Application of Pharmacogenetic Markers in the Treatment of Dermatologic Pathologies

Dermatologic pathologies are the fourth most common cause of non-fatal disease worldwide; however, they produce a psychosocial, economic, and occupational impact equal to or greater than other chronic conditions. The most prevalent are actinic keratosis, followed by basal-cell carcinoma, in a lesser...

Full description

Bibliographic Details
Main Authors: Cristina Membrive Jiménez, Cristina Pérez Ramírez, Almudena Sánchez Martín, Sayleth Vieira Maroun, Salvador Arias Santiago, María Carmen Ramírez Tortosa, Alberto Jiménez Morales
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Pharmaceuticals
Subjects:
dermatology
polymorphisms
mutations
response
toxicity
biologic therapy
Online Access:https://www.mdpi.com/1424-8247/14/9/905

Internet

https://www.mdpi.com/1424-8247/14/9/905

Similar Items